BIOCRYST PHARMACEUTICALS INC Federal Contracts — Government Award History
Total (All Time)$17M
Latest FY$541,758
Primary AgencyDepartment of Veterans Affairs
BIOCRYST PHARMACEUTICALS INC has received $17M in total federal contract awards
across 3 fiscal year(s). ▼ 51.3% vs FY2025 Peak year was FY2024 ($15M).
Primary awarding agency: Department of Veterans Affairs.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2026 | $541,758 | 3건 | Department of Veterans Affairs | |
| FY2025 | $1.1M | 3건 | Department of Veterans Affairs | |
| FY2024 | $15.0M | 6건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2007-01-03 | Department of Health and Human Services | $205.3M | ADVANCE DEVELOPMENT OF NEW ANTIVIRAL AGENT FOR INFLUENZA |
| 2013-09-16 | Department of Health and Human Services | $47.3M | IGF::OT::IGF – DEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGI |
| 2018-09-01 | Department of Health and Human Services | $34.7M | PERAMIVIR, RAPIVAB FLU TREATMENT |
| 2024-09-30 | Department of Health and Human Services | $13.9M | PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN)) |
| 2015-03-31 | Department of Health and Human Services | $11.9M | IGF::CT::IGF BIOCRYST PHARMACEUTICALS |
| 2020-09-01 | Department of Health and Human Services | $6.3M | COVID-19. TO MANUFACTURE AND EVALUATE THE SAFETY, EFFICACY AND TOLERABILITY OF G |
| 2024-03-12 | Department of Veterans Affairs | $385,448 | BULK ORDER ORLADEYO |
| 2025-03-12 | Department of Veterans Affairs | $385,448 | BULK ORLADEYO PHARMACEUTICAL |
| 2025-09-09 | Department of Veterans Affairs | $382,301 | BULK ORDER ORLADEYO FOR VETERAN CARE. |
| 2024-09-09 | Department of Veterans Affairs | $374,626 | BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP |
| 2022-06-01 | Department of Veterans Affairs | $368,683 | BEROTRALSTAT HCL 150MG CAP,ORAL BULK, 72769-0101-01 |
| 2025-10-01 | Department of Veterans Affairs | $360,000 | PHARM – ORLADEYO |
| 2024-10-01 | Department of Veterans Affairs | $345,808 | BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO). |
| 2023-01-20 | Department of Veterans Affairs | $340,322 | BEROTRALSTAT |
| 2024-03-04 | Department of Veterans Affairs | $201,722 | ORLADEYO 150MG CAPS |
| 2026-05-19 | Department of Veterans Affairs | $151,465 | ORLADEYO 150MG CAP |
| 2024-02-20 | Department of Veterans Affairs | $88,950 | ORLADEYO EMERGENT |
| 2022-03-08 | Department of Veterans Affairs | $85,081 | BEROTRALSTAT (ORLADEYO) 150MG |
| 2026-05-21 | Department of Veterans Affairs | $30,293 | EMERGENCY ORLADEYO |
| 2024-02-16 | Department of Veterans Affairs | $29,650 | BEROTRALSTAT |